At 3 mg/kg, LAS101057 is effective in preventing Acetyl-β-methylcholine-induced airway hyperresponsiveness (AHR), and at 10 mg/kg, it inhibits AHR to Acetyl-β-methylcholine to a level virtually equal to that seen with Hexadecadrol at 1 mg/kg[1].